凱瑞(rui)斯(si)德成(cheng)立于(yu)(yu)(yu)2000年,擁(yong)有(you)國(guo)際(ji)先進的(de)(de)(de)不對(dui)稱氫(qing)化(hua)技(ji)術(shu),致力(li)于(yu)(yu)(yu)為(wei)(wei)全球創新(xin)藥(yao)(yao)公(gong)司(si)提(ti)(ti)供(gong)中(zhong)間體定(ding)制生產(chan)服(fu)務(wu),包括(kuo)研(yan)發(fa)、中(zhong)試到商業化(hua)生產(chan)。公(gong)司(si)總部及研(yan)發(fa)中(zhong)心位(wei)于(yu)(yu)(yu)蘇(su)(su)州工(gong)(gong)(gong)業園區(qu),2009年凱瑞(rui)斯(si)德收購(gou)江(jiang)西隆萊生物(wu)制藥(yao)(yao)有(you)限公(gong)司(si)作為(wei)(wei)公(gong)司(si)的(de)(de)(de)生產(chan)基地。生產(chan)基地位(wei)于(yu)(yu)(yu)江(jiang)西省進賢(xian)縣工(gong)(gong)(gong)業園區(qu),另(ling)外(wai),公(gong)司(si)在美(mei)國(guo)、歐洲和印度都設有(you)辦事處。公(gong)司(si)以(yi)(yi)技(ji)術(shu)為(wei)(wei)依托、以(yi)(yi)人才為(wei)(wei)根本,已(yi)獲(huo)得(de)國(guo)家高新(xin)技(ji)術(shu)企業、蘇(su)(su)州市(shi)不對(dui)稱氫(qing)化(hua)工(gong)(gong)(gong)程(cheng)技(ji)術(shu)研(yan)究中(zhong)心、蘇(su)(su)州工(gong)(gong)(gong)業園區(qu)科技(ji)“雙百工(gong)(gong)(gong)程(cheng)”企業和江(jiang)蘇(su)(su)省博士(shi)后創新(xin)實(shi)踐(jian)基地等認證。并擁(yong)有(you)13項手性催(cui)化(hua)劑和配(pei)體的(de)(de)(de)國(guo)際(ji)專(zhuan)利(li),8項仿制藥(yao)(yao)合成(cheng)新(xin)工(gong)(gong)(gong)藝專(zhuan)利(li)。凱瑞(rui)斯(si)德的(de)(de)(de)宗旨(zhi)是利(li)用技(ji)術(shu)優勢,為(wei)(wei)全球生物(wu)醫藥(yao)(yao)公(gong)司(si)提(ti)(ti)供(gong)可(ke)靠(kao)的(de)(de)(de)醫藥(yao)(yao)中(zhong)間體和原料藥(yao)(yao),同時提(ti)(ti)供(gong)新(xin)藥(yao)(yao)研(yan)發(fa)服(fu)務(wu)。
凱瑞斯德(de)研發(fa)(fa)中(zhong)心(xin)位于蘇州工業(ye)園區(qu)生(sheng)物納米園,公司擁有高層次的研發(fa)(fa)團隊,其中(zhong)博士(shi)7人,海外專家5人,碩士(shi)13人。公司開發(fa)(fa)的手性(xing)催(cui)化(hua)劑具有高效、高選擇性(xing)、低成本和多(duo)種底物普遍適(shi)用性(xing)等特點。這些(xie)催(cui)化(hua)劑已經(jing)成功商業(ye)化(hua),并應用于多(duo)種手性(xing)高級醫藥中(zhong)間體的合(he)成。